Self-Sampling could boost cervical cancer screening for women with HIV

NCT ID NCT06800664

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a program to help women living with HIV in Ghana get screened for cervical cancer more easily. The program includes self-sampling kits, patient navigators, and training for healthcare providers. Researchers want to see if these tools increase screening rates and can be adopted by local clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention (self-sampling, 3R model, patient navigators, and implementation support strategies)
What this could lead to
If successful, this could make cervical cancer screening more accessible and routine for women with HIV in Ghana, potentially reducing cancer deaths in this high-risk group.
What could go wrong
This is an implementation study, not a direct treatment trial. Success depends on healthcare system adoption, and results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Cape Coast

    RECRUITING

    Cape Coast, Central Region, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.